The National Health and Medical Research Council (NHMRC), the Australian Government’s medical research funder and regulator, has joined AllTrials. The NHMRC oversees medical research in Australia and established the Australian New Zealand Clinical Trials Register (ANZCRT). Around 100 clinical trials are registered each month on the ANZCTR with close to 10,000 registered by the […]
Patients’ and doctors’ campaign welcomes plans to tackle unjust and dangerous problem of hidden clinical trials
The AllTrials campaign, which has been calling for all clinical trials past and present to be registered, and full methods and results made available, today welcomed new proposals by the US Department of Health and Human Services (HHS) and National Institutes of Health (NIH) to expand reporting of clinical trial results, and to make that […]
The European Ombudsman, Emily O’Reilly, has asked the European Medicines Agency (EMA) why it agreed to keep large amounts of information hidden about clinical trials on the medicine Humira. AbbVie, the manufacturer of Humira, had sued the EMA to keep the information confidential. As part of a settlement announced in April, the EMA agreed to […]
A review of the individual patient data from 12 clinical trials showed that chemotherapy provided a small but significant increase in survival among people with the most common type of brain tumour.
Malignant gliomas are a deadly cancer of the brain and spine, most common in childhood and at age 50-60 years. Treatment generally involves […]
Following an analysis of individual patient data (IPD), doctors were able to offer a less painful surgery to treat the most common type of hernia.
When people age, muscles become weaker and the intestines can sometimes push through weak spots causing a hernia. These can be painful and in some cases require surgery to treat. […]
To lay bare the benefits and harms about medicines, researchers often need to get into the nitty-gritty details found in the data from the participants in clinical trials. Summary results often just don’t cut it. This week, AllTrials will be highlighting some of the research that demonstrates the benefits of these detailed analyses to […]
Clinical trials funded by a large US funder will have to be registered before they begin and their results made available within one year of completion under its proposed policy. The Patient Centered Outcomes Research Institute (PCORI) is currently deciding how it will make the findings from research that it funds public. Since it […]
In a new post on PLOS Blogs, Tom Jefferson looks at what Europe’s medicines body’s new policy on releasing information from clinical trials might mean for journals and researchers who combine clinical trial information in systematic reviews. This is the policy that that hundreds of you wrote to the European Medicines Agency about. Jefferson, who […]
The Society of Biology, a UK learned society for academics, industry, and researchers in biology, has just joined AllTrials. This is fantastic, the Society represents 90 organisation and 14,000 individual members.
Here is the Society of Biology’s statement:
The Society of Biology is pleased to announce its support for aims of the AllTrials petition. The Society […]
We have a chance to get the most influential health body in the world – the World Health Organisation (WHO) – to say something strong on the need for the results of all clinical trials to be publicly reported. Following all of our pressure, the WHO has decided it needs to say something about […]